In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Kayano, Ana Carolina A V ^a   Lopes, Stefanie C P ^a   Bueno, Fernanda G ^b   Cabral, Elaine C ^a   Souza Neiras, Wanessa C ^a   Yamauchi, Lucy M ^c   Foglio, Mary A ^a   Eberlin, Marcos N ^a   Mello, Joo Carlos P ^b   Costa, Fabio T M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIMALARIAL AGENT; ARTESUNATE; METHANOL; PLANT EXTRACT; QUERCETIN; ARTEMISININ DERIVATIVE;

ANTIMALARIAL ACTIVITY; ARTICLE; CAESALPINIA; CAESALPINIA PLUVIOSA; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETER; MOUSE; NONHUMAN; PARASITEMIA; PLANT STEM; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; ANIMAL; BARK; BRAZIL; C57BL MOUSE; CELL LINE; CELL SURVIVAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; ISOLATION AND PURIFICATION; MALARIA; MEDICINAL PLANT; PARASITOLOGY; RODENT DISEASE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BRAZIL; CAESALPINIA; CELL LINE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HUMANS; MALARIA; MICE; MICE, INBRED C57BL; PLANT BARK; PLANT EXTRACTS; PLANTS, MEDICINAL; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; QUERCETIN; RODENT DISEASES;

EID: 79958852466     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-112     Document Type: Article

References (54)

1. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. J Le Bras R Durand, Fundam Clin Pharmacol 2003 17 147 153 10.1046/j.1472-8206.2003.00164.x 12667224 (Pubitemid 36513205)
2. Antimalarials and the fight against malaria in Brazil. LMA Camargo S Oliveira S Basano CRS Garcia, Ther Clin Risk Manag 2009 5 311 317 19753125
3. Antimalarial drugs and their useful therapeutic lives: Rational drug design lessons from pleiotropic action of quinolines and artemisinins. FW Muregi, Curr Drug Discov Technol 2010 7 280 316 10.2174/157016310793360693 21034413
4. The selection landscape of malaria parasites. MJ Mackinnon K Marsh, Science 2010 328 866 871 10.1126/science.1185410 20466925
5. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
6. Artemisinin resistance in Plasmodium falciparum malaria. AM Dondorp F Nosten P Yi D Das AP Phyo J Tarning KM Lwin F Ariey W Hanpithakpong SJ Lee P Ringwald K Silamut M Imwong K Chotivanich P Lim T Herdman SS An S Yeung P Singhasivanon NP Day N Lindegardh D Socheat NJ White, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
7. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. H Noedl Y Se S Sriwichai K Schaecher P Teja-Isavadharm B Smith W Rutvisuttinunt D Bethell S Surasri MM Fukuda D Socheat L Chan Thap, Clin Infect Dis 2010 51 82 89 10.1086/657120
8. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. S Saralamba W Pan-Ngum RJ Maude SJ Lee J Tarning N Lindegårdh K Chotivanich F Nosten NP Day D Socheat NJ White AM Dondorp LJ White, Proc Natl Acad Sci USA 2011 108 397 402 10.1073/pnas.1006113108 21173254
9. Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite. LA Rodrigues G Henriques ST Borges P Hunt CP Sanchez A Martinelli P Cravo, PLoS One 2010 5 11593 10.1371/journal.pone.0011593 20657645
10. In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes. EH Ekland DA Fidock, Int J Parasitol 2008 38 743 747 10.1016/j.ijpara.2008.03.004 18406409
11. The Plasmodium sporozoite survives RTS, S vaccination. G Snounou AC Grüner CD Müller-Graf D Mazier L Rénia, Trends Parasitol 2005 21 456 461 10.1016/j.pt.2005.08.002 16109504 (Pubitemid 41297748)
12. New antiviral cassane furanoditerpenes from Caesalpinia minax. RW Jiang SC Ma PP But TC Mak, J Nat Prod 2001 64 1266 1272 10.1021/np010174+ 11678648 (Pubitemid 33029204)
13. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. LC Chiang W Chiang MC Liu CC Lin, J Antimicrob Chemother 2003 52 194 198 10.1093/jac/dkg291 12837746 (Pubitemid 36986878)
14. In vitro anti-influenza viral activities of constituents from Caesalpinia sappan. AL Liu SH Shu HL Qin SM Lee YT Wang GH Du, Planta Med 2009 75 337 339 10.1055/s-0028-1112208 19148862
15. In vitro antimicrobial activity of Caesalpinia ferrea Martius fruits against oral pathogens. MSV Pereira CS Dias VCO Costa NCO Conde MAR Buzalaf, J Ethnopharm 2009 124 289 294 10.1016/j.jep.2009.04.034
16. In vitro and in vivo antimicrobial activities of seeds of Caesalpinia bonduc (Lin.) Roxb. T Arif TK Mandal N Kumar JD Bhosale A Hole GL Sharma MM Padhi GS Lavekar R Dabur, J Ethnopharm 2009 123 177 180 10.1016/j.jep.2009.02. 040
17. Anti-inflammatory activities of flavonoids isolated from Caesalpinia pulcherrima. YK Rao S-H Fang Y-M Tzeng, J Ethnopharm 2005 100 249 253 10.1016/j.jep.2005.02.039 (Pubitemid 41206619)
18. Potential anti-inflammatory diterpenoids from the roots of Caesalpinia mimosoides Lamk. O Yodsaoue C Karalai C Ponglimanont S Tewtrakul S Chantrapromma, Phytochem 2010 71 1756 1764 10.1016/j.phytochem.2010.06.016
19. Assessment of the antioxidant and reactive oxygen species scavenging activity of methanolic extract of Caesalpinia crista leaf. S Mandal B Hazra R Sarkar S Biswas N Mandal, eCAM 2009
20. Antioxidant acitivity and total phenolic content of ethanolic extract of Caesalpinia bonducella seeds. S Shukla A Mehta J John S Singh P Mehta SP Vyas, Food Chem Toxicol 2009 47 1848 1851 10.1016/j.fct.2009.04.040 19422871
21. A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part V. Evaluation of the antimalarial activity of plants used by the Tacana Indians. E Deharo G Bourdy V Munz G Ruiz M Sauvain, J Ethnopharm 2001 77 91 98 10.1016/S0378-8741(01)00270-7 (Pubitemid 32727750)
22. Genetic analysis of the human malaria parasite Plasmodium falciparum. D Walliker IA Quakyi TE Wellems TF McCutchan A Szarfman WT London LM Corcoran TR Burkot R Carter, Science 1987 236 1661 1666 10.1126/science.3299700 3299700 (Pubitemid 17091020)
23. Characterization of Plasmodium falciparum strains of the State of Rondonia, Brazil, using microtests of sensitivity to antimalarials, enzyme typing and monoclonal antibodies. SM Di Santi M Boulos MA Vasconcelos S Oliveira A Couto VE Rosrio, Rev Inst Med Trop So Paulo 1987 29 142 147 10.1590/S0036-46651987000300005
24. Human malaria parasites in continuous culture. W Trager JB Jensen, Science 1976 193 673 675 10.1126/science.781840 781840
25. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. T Mosmann, J Immunol Methods 1983 65 55 63 10.1016/0022-1759(83)90303-4 6606682 (Pubitemid 14203433)
26. A human cell line from a pleural effusion derived from a breast carcinoma. HD Soule J Vazguez A Long S Albert M Brennan, J Natl Cancer Inst 1973 51 1409 1416 4357757
27. The cost-effectiveness of screening strategies for amblyopia: a preliminary report. S Schlichtherle A Gandjour A Neugebauer W Rüssmann KW Lauterbach, Strabismus 2000 8 291 295 10.1076/stra.8.4.291.685 11262690 (Pubitemid 32234188)
28. The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. W Peters BL Robinson, Ann Trop Med Parasitol 1992 86 455 465 1288426 (Pubitemid 23040785)
29. In vitro and in vivo properties of ellagic acid in malaria treatment. PN Soh B Witkowski D Olagnier ML Nicolau MC Garcia-Alvarez A Berry F Benoit-Vical, Antimicrob Agents Chemother 2009 53 1100 1106 10.1128/AAC.01175-08 19015354
30. Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo. SC Lopes YC Blanco GZ Justo PA Nogueira FL Rodrigues U Goelnitz G Wunderlich G Facchini M Brocchi N Duran FT Costa, Antimicrob Agents Chemother 2009 53 2149 2152 10.1128/AAC.00693-08 19273690
31. In vitro antimalarial activity of tetrahydrofoliate dehydrogenase inhibitors. DG Sixsmith WM Watkins JD Chulay HC Spencer, Am J Trop Med Hyg 1984 33 772 776 6385738 (Pubitemid 15201685)
32. A method for testing for synergy with any number of agents. MC Berenbaum, J Infect Dis 1978 137 122 130 10.1093/infdis/137.2.122 627734 (Pubitemid 8289152)
33. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. S Gupta MM Thapar WH Wernsdorfer A Björkman, Antimicrob Agents Chemother 2002 46 1510 1515 10.1128/AAC.46.5.1510-1515.2002 11959589 (Pubitemid 34415335)
34. Aldose reductase inhibitors from the fruits of Caesalpinia ferrea Mart. H Ueda Y Tachibana M Moriyasu K Kawanishi SM Alves, Phytomedicine 2001 8 377 381 10.1078/0944-7113-00043 11695881 (Pubitemid 32983058)
35. Protosappanin C from Sappan lignum and absolute configuration of protosappanins. M Nagai S Nagumo, Chem Pharm Bull 1987 35 3002 3005
36. A new 3-benzylchroman derivative from Sappan lignum (Caesalpinia sappan). L-C Fu X-an Huang Z-yuan Lai Y-jie Hu H-jiao Liu X-ling Cai, Molecules 2008 13 1923 1930 10.3390/molecules13081923 18794793
37. Chemical examination of the flowers of Caesalpinia pulcherrima. GR Prasad, Indian J Pharm Sci 1978 40 103 104 (Pubitemid 9108333)
38. Diterpenoids from Caesalpinia pulcherrima. DD McPherson C-T Che GA Cordell DD Soejarto JM Pezzuto HHS Fong, Phytochemistry 1985 25 167 170 10.1016/S0031-9422(00)94522-9
39. A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part IV. Is a new haem polymerisation inhibition test pertinent for the detection of antimalarial natural products? R Baelmans E Deharo G Bourdy V Mũoz C Quenevo M Sauvain H Ginsburg, J Ethnopharmacol 2000 73 271 275 10.1016/S0378-8741(00)00330-5 11025165
40. Chemical composition and antimicrobial activity of the extracts of Kefe cumin (Laser trilobum L.) fruits from different regions. A Parlatan C Sariçoban MM zcan, Int J Food Sci Nutr 2008 26 1 12
41. Simultaneous determination of 13 bioactive compounds in Herba Artemisia scopariae (Yin Chen) from different harvest seasons by HPLC-DAD. XJ Tan Q Li XH Chen ZW Wang ZY Shi KS Bi Y Jia, J Pharm Biomed Anal 2008 47 847 853 10.1016/j.jpba.2008.04.010 18502075
42. Antimalarial activity of some Colombian medicinal plants. G Garavito J Rincán L Arteaga Y Hata G Bourdy A Gimenez R Pinzán E Deharo, J Ethnopharmacol 2006 107 460 462 10.1016/j.jep.2006.03.033 16713157 (Pubitemid 44344435)
43. Antiplasmodial activity of Punica granatum L. fruit rind. M Dell'Agli GV Galli Y Corbett D Taramelli L Lucantoni A Habluetzel O Maschi D Caruso F Giavarini S Romeo D Bhattacharya E Bosisio, J Ethnopharmacol 2009 125 279 285 10.1016/j.jep.2009.06.025 19577622
44. Malaria's drug miracle in danger. M Enserink, Science 2010 328 844 846 10.1126/science.328.5980.844 20466917
45. Plasmodium falciparum: in vitro interaction of quassin and neo-quassin with artesunate, a hemisuccinate derivative of artemisinin. K Mishra D Chakraborty A Pal N Dey, Exp Parasitol 2010 124 421 427 10.1016/j.exppara.2009. 12.007 20036657
46. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. LC Chiang W Chiang MC Liu CC Lin, J Antimicrob Chemother 2003 52 194 198 10.1093/jac/dkg291 12837746 (Pubitemid 36986878)
47. Three new cassane diterpenes from the seeds of Caesalpinia minax Hance. ZH Wu J Huang WD Li LJ Wu HY Gao, J Asian Nat Prod Res 2010 12 781 787 10.1080/10286020.2010.504661 20839126
48. Potential anti-inflammatory diterpenoids from the roots of Caesalpinia mimosoides Lamk. O Yodsaoue C Karalai C Ponglimanont S Tewtrakul S Chantrapromma, Phytochemistry 2010 71 1756 1764 10.1016/j.phytochem.2010.06.016 20656305
49. New diterpenoids from Caesalpinia species and their cytotoxic activity. B Das Y Srinivas C Sudhakar I Mahender K Laxminarayana PR Reddy TV Raju NM Jakka JV Rao, Bioorg Med Chem Lett 2010 20 2847 2850 10.1016/j.bmcl.2010.03.048 20356735
50. Isolation, synthesis, and bioactivity of homoisoflavonoids from Caesalpinia pulcherrima. B Das P Thirupathi B Ravikanth R Aravind Kumar AV Sarma SJ Basha, Chem Pharm Bull 2009 57 1139 1141 10.1248/cpb.57.1139 19801876
51. Biflavonoids and other phenolics from Caesalpinia pyramidalis (Fabaceae). MV Bahia JB Dos Santos PD Juceni JM David, J Braz Chem Soc 2005 16 1402 1405 10.1590/S0103-50532005000800017 (Pubitemid 43104523)
52. Optimizing conditions for gallic acid extraction from Caesalpinia decapetala wood. CR Pawar SJ Surana, Pak J Pharm Sci 2010 23 423 425 20884457
53. Antimalarial compounds isolated from plants used in traditional medicine. J Bero M Frédérich J Quentin-Leclercq, J Pharm Pharmacol 2009 61 1401 1433 19903367
54. Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes. M del Rayo Camacho JD Phillipson SL Croft D Marley GC Kirby DC Warhurst, J Nat Prod 2002 65 1457 1461 10.1021/np010419i 12398543 (Pubitemid 35239633)